Carl Koschmann MD
Pediatric Neuro-Oncology
Associate Professor
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Koschmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
University of Michigan Health SystemPost-Doctoral Fellowship, Pediatric Neuro-Oncology, 2014 - 2015- University of MichiganFellowship, Pediatric Hematology/Oncology, 2011 - 2014
University of WashingtonResidency, Pediatrics, 2007 - 2010
University of Wisconsin School of Medicine & Public HealthClass of 2007
Certifications & Licensure
MI State Medical License 2011 - 2027
WA State Medical License 2007 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations Start of enrollment: 2017 Dec 06
- Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
- Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma Start of enrollment: 2019 Nov 30
Publications & Presentations
PubMed
- Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.Lisa Mayr, Sina Neyazi, Kallen Schwark, Maria Trissal, Alexander Beck
Cancer Cell. 2025-03-13 - Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma.Luke McVeigh, Tirth Patel, Madeline Miclea, Kallen Schwark, Diala Ajaero
Cancers. 2025-03-10 - 1 citationsThe Open Pediatric Cancer Project.Zhuangzhuang Geng, Eric Wafula, Ryan J Corbett, Yuanchao Zhang, Run Jin
Biorxiv. 2025-03-01
Press Mentions
Repurposed Drug Treats Aggressive Pediatric Brain TumorMarch 18th, 2025
Repurposed Cancer Drug Demonstrates Potential to Treat High-Grade GliomasMarch 14th, 2025- Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual MeetingApril 19th, 2023
- Join now to see all
External Links
- Koschmann Labhttp://www.koschmannlab.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
